221 related articles for article (PubMed ID: 21276781)
21. Inhibitory effects of the essential oil of chamomile (Matricaria recutita L.) and its major constituents on human cytochrome P450 enzymes.
Ganzera M; Schneider P; Stuppner H
Life Sci; 2006 Jan; 78(8):856-61. PubMed ID: 16137701
[TBL] [Abstract][Full Text] [Related]
22. Investigation of CYP3A4 and CYP2D6 Interactions of Withania somnifera and Centella asiatica in Human Liver Microsomes.
Savai J; Varghese A; Pandita N; Chintamaneni M
Phytother Res; 2015 May; 29(5):785-90. PubMed ID: 25684704
[TBL] [Abstract][Full Text] [Related]
23. A simple isocratic HPLC method for the simultaneous determination of sinensetin, eupatorin, and 3'-hydroxy-5,6,7,4'-tetramethoxyflavone in Orthosiphon stamineus extracts.
Yam MF; Mohamed EA; Ang LF; Pei L; Darwis Y; Mahmud R; Asmawi MZ; Basir R; Ahmad M
J Acupunct Meridian Stud; 2012 Aug; 5(4):176-82. PubMed ID: 22898066
[TBL] [Abstract][Full Text] [Related]
24. Optimizing higher throughput methods to assess drug-drug interactions for CYP1A2, CYP2C9, CYP2C19, CYP2D6, rCYP2D6, and CYP3A4 in vitro using a single point IC(50).
Gao F; Johnson DL; Ekins S; Janiszewski J; Kelly KG; Meyer RD; West M
J Biomol Screen; 2002 Aug; 7(4):373-82. PubMed ID: 12230892
[TBL] [Abstract][Full Text] [Related]
25. Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant.
Brown HS; Ito K; Galetin A; Houston JB
Br J Clin Pharmacol; 2005 Nov; 60(5):508-18. PubMed ID: 16236041
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory effects of the monoamine oxidase inhibitor tranylcypromine on the cytochrome P450 enzymes CYP2C19, CYP2C9, and CYP2D6.
Salsali M; Holt A; Baker GB
Cell Mol Neurobiol; 2004 Feb; 24(1):63-76. PubMed ID: 15049511
[TBL] [Abstract][Full Text] [Related]
27. Flavonoids-Rich Orthosiphon stamineus Extract as New Candidate for Angiotensin I-Converting Enzyme Inhibition: A Molecular Docking Study.
Shafaei A; Sultan Khan MS; F A Aisha A; Abdul Majid AM; Hamdan MR; Mordi MN; Ismail Z
Molecules; 2016 Nov; 21(11):. PubMed ID: 27834876
[TBL] [Abstract][Full Text] [Related]
28. Reversible inhibition of three important human liver cytochrome p450 enzymes by tiliroside.
Sun DX; Lu JC; Fang ZZ; Zhang YY; Cao YF; Mao YX; Zhu LL; Yin J; Yang L
Phytother Res; 2010 Nov; 24(11):1670-5. PubMed ID: 21031626
[TBL] [Abstract][Full Text] [Related]
29. In vitro inhibition of methadone and oxycodone cytochrome P450-dependent metabolism: reversible inhibition by H2-receptor agonists and proton-pump inhibitors.
Moody DE; Liu F; Fang WB
J Anal Toxicol; 2013 Oct; 37(8):476-85. PubMed ID: 23857299
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
Obach RS
J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
[TBL] [Abstract][Full Text] [Related]
31. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.
Tachibana S; Fujimaki Y; Yokoyama H; Okazaki O; Sudo K
Drug Metab Dispos; 2005 Nov; 33(11):1628-36. PubMed ID: 16049129
[TBL] [Abstract][Full Text] [Related]
32. Cytochrome P450 inhibition activities of non-standardized botanical products.
Abduraman MA; Mustafa NH; Yaacob NS; Amanah A; Tan ML
J Ethnopharmacol; 2022 Oct; 296():115406. PubMed ID: 35659627
[TBL] [Abstract][Full Text] [Related]
33. Isolation, synthesis, and drug interaction potential of secondary metabolites derived from the leaves of miracle tree (Moringa oleifera) against CYP3A4 and CYP2D6 isozymes.
Fantoukh OI; Albadry MA; Parveen A; Hawwal MF; Majrashi T; Ali Z; Khan SI; Chittiboyina AG; Khan IA
Phytomedicine; 2019 Jul; 60():153010. PubMed ID: 31301970
[TBL] [Abstract][Full Text] [Related]
34. CYP450 mediated inhibition potential of Swertia chirata: An herb from Indian traditional medicine.
Ahmmed SM; Mukherjee PK; Bahadur S; Harwansh RK; Kar A; Bandyopadhyay A; Al-Dhabi NA; Duraipandiyan V
J Ethnopharmacol; 2016 Feb; 178():34-9. PubMed ID: 26657265
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity.
Kimura Y; Ito H; Ohnishi R; Hatano T
Food Chem Toxicol; 2010 Jan; 48(1):429-35. PubMed ID: 19883715
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes.
Qi XY; Liang SC; Ge GB; Liu Y; Dong PP; Zhang JW; Wang AX; Hou J; Zhu LL; Yang L; Tu CX
Food Chem Toxicol; 2013 Jun; 56():392-7. PubMed ID: 23500771
[TBL] [Abstract][Full Text] [Related]
37. Automated screening with confirmation of mechanism-based inactivation of CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2 in pooled human liver microsomes.
Lim HK; Duczak N; Brougham L; Elliot M; Patel K; Chan K
Drug Metab Dispos; 2005 Aug; 33(8):1211-9. PubMed ID: 15860655
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effects of deoxypodophyllotoxin from Anthriscus sylvestris on human CYP2C9 and CYP3A4.
Lee SK; Kim Y; Jin C; Lee SH; Kang MJ; Jeong TC; Jeong SY; Kim DH; Yoo HH
Planta Med; 2010 May; 76(7):701-4. PubMed ID: 19960413
[TBL] [Abstract][Full Text] [Related]
39. Antiproliferative and antiangiogenic effects of flavone eupatorin, an active constituent of chloroform extract of Orthosiphon stamineus leaves.
Dolečková I; Rárová L; Grúz J; Vondrusová M; Strnad M; Kryštof V
Fitoterapia; 2012 Sep; 83(6):1000-7. PubMed ID: 22698713
[TBL] [Abstract][Full Text] [Related]
40. Phytochemical profile of Orthosiphon aristatus extracts after storage: Rosmarinic acid and other caffeic acid derivatives.
Chua LS; Lau CH; Chew CY; Ismail NIM; Soontorngun N
Phytomedicine; 2018 Jan; 39():49-55. PubMed ID: 29433683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
